Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19479070 | 0.88 | MAPK1 (0.30) | MAPK1HRH3 | |
| SCHEMBL28610109 | 0.80 | HRH3 (0.32) | HRH3MCHR1 | |
| SCHEMBL18025231 | 0.79 | HRH3 (0.36) | HRH3 | |
| SCHEMBL11938124 | 0.78 | — | — | |
| SCHEMBL17708098 | 0.78 | — | — | |
| SCHEMBL18254224 | 0.78 | — | — | |
| SCHEMBL24974724 | 0.78 | — | — | |
| SCHEMBL16316437 | 0.75 | — | — | |
| SCHEMBL11922164 | 0.75 | MAPK1 (0.31) | MAPK1HRH3 | |
| SCHEMBL7752093 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4128392-A1 | LITHIUM-ION BATTERY WITH ANODE COMPRISING BLEND OF INTERCALATION-TYPE ANODE MATERIAL AND CONVERSION-TYPE ANODE MATERIAL | Sila Nanotechnologies Inc. (US) | 2023-02-08 | — | — | EP | disclosed |
| US-20210313617-A1 | LITHIUM-ION BATTERY WITH ANODE COMPRISING BLEND OF INTERCALATION-TYPE ANODE MATERIAL AND CONVERSION-TYPE ANODE MATERIAL | SILA NANOTECHNOLOGIES, INC. | 2021-10-07 | — | — | US | disclosed |
| WO-2021203086-A1 | LITHIUM-ION BATTERY WITH ANODE COMPRISING BLEND OF INTERCALATION-TYPE ANODE MATERIAL AND CONVERSION-TYPE ANODE MATERIAL | SILA NANOTECHNOLOGIES INC. (US) | 2021-10-07 | — | — | WO | disclosed |
| US-20160237302-A1 | WATERBORNE COMPOSITIONS | CALLAGHAN INNOVATION RESEARCH LIMITED (NZ) | 2016-08-18 | — | — | US | disclosed |
| EP-2065387-B1 | Quartz glass micro-photoreactors and synthesis of 10-hydroxycamptothecin and 7-alkyl-10-hydroxycamptothecin | HERAEUS GMBH W C (DE) | 2011-01-19 | — | — | EP | disclosed |
| EP-2065387-A2 | Quartz glass micro-photoreactors and synthesis of 10 hydroxycamptothecin and 7-alkyl-10-hydroxycamptothecin | W.C. Heraeus GmbH (DE) | 2009-06-03 | — | — | EP | disclosed |
| US-7276505-B2 | Immunomodulating heterocyclic compounds | MEDIGENE LIMITED (GB) | 2007-10-02 | — | — | US | disclosed |
| US-20070021428-A1 | Immunomodulating heterocyclic compounds | AVIDEX LIMITED (GB) | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070021428-A1 | Immunomodulating heterocyclic compounds | CD40, CD40LG, NGFR | MAPK1 2194/4885HRH3 34/4885MCHR1 738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.